Julian Witt

Senior Physician, Cardiac Surgery, Albertinen Cardiovascular Center

Vita

Julian Witt has been Senior Physician, Department of Percutaneous Treatment of Structural Heart Diseases, Clinic of Cardiac Surgery, Cardiovascular Center, Albertinen Hospital, since 2019. This is the focus of his medical work, as well as cardiac MRI.

After studying medicine, he began training as a cardiac surgeon at Christian Albrecht University in Kiel. In August 2001, Julian Witt moved to Albertinen Hospital and began his specialist training in internal medicine and cardiology. In addition to intensive care, his focus from the beginning has been on interventional cardiology and cardiac MRI. From 2014 to 2019, Julian Witt worked closely with Prof. Schofer in the field of percutaneous treatment of structural heart disease.

Quote from Wallenstein's Camp, by Friedrich Schiller: "Live and let live"

Julian Witt, Leitender Arzt Department für die perkutane Behandlung struktureller Herzerkrankungen

1968	born in Kiel, married, no children
seit 2019	Senior Physician in the Department of Percutaneous Treatment of Structural Heart Diseases, Cardiac Surgery Clinic, Cardiovascular Center, Albertinen Hospital
2017	Specialist Physician in Internal Medicine
2005 - 2019	Senior Physician in Cardiology, Albertinen Hospital
2001 - 2005	Assistant Physician in Cardiology, Albertinen Hospital
1996 - 2001	Assistant Physician in Cardiac Surgery, Christian Albrecht University of Kiel
1995 - 1996	Internship in Cardiac Surgery, Christian Albrecht University of Kiel
1989 - 1995	Medical studies at Christian Albrecht University of Kiel

Focus

Special professional qualifications

2018: Additional specialty in interventional cardiology
2011: Expertise in radiation protection
2004: Additional specialty in emergency medicine

Teaching assignment/Positions/Functions/Memberships

German Cardiac Society (DGK)

Selected publications

Does valve in valve TAVR carry a higher risk for thromboembolic events compared to native valve TAVR? Eitan A, Brinkmann C, Haselbach T, Witt J, Schofer J. Catheter Cardiovasc Interv. 2020 Apr 1;95(5):1017-1021. doi: 10.1002/ccd.28391. Epub 2019 Jul 9. PMID: 31290241
Percutaneous treatment of anterior mitral leaflet perforation using an AMPLATZER Septal Occluder. Tiburtius C, Witt J, Schofer J.EuroIntervention. 2018 Dec 20;14(12):e1286-e1287. doi: 10.4244/EIJ-D-18-00794. PMID: 30175962 No abstract available.
Combined jugular and femoral approach for treating severe tricuspid valve regurgitation. Eitan A, Tiburtius C, Witt J, Schofer J.EuroIntervention. 2018 Jan 20;13(13):1538-1539. doi: 10.4244/EIJ D-17-00662. PMID: 28846546 No abstract available.
Performance of the Evolut-R 34 mm versus Sapien-3 29 mm in Transcatheter aortic valve replacement patients with larger annuli: Early outcome results of Evolut-R 34 mm as compared with Sapien-3 29 mm in patients with Annuli ≥26 mm. Eitan A, Witt J, Stripling J, Haselbach T, Rieß FC, Schofer J. Catheter Cardiovasc Interv. 2018 Dec 1;92(7):1374-1379. doi: 10.1002/ccd.27588. Epub 2018 Mar 9. PMID: 29521464 Clinical Trial.
Tricuspid regurgitation is a predictor of mortality after percutaneous mitral valve edge-to-edge repair. Yzeiraj E, Bijuklic K, Tiburtius C, Witt J, Krause K, Steude J, Hansen L, Rieß FC, Schofer J. EuroIntervention. 2017 Feb 3;12(15):e1817-e1824. doi: 10.4244/EIJ-D-16-00909. PMID: 28117278
Transfemoral Tricuspid Valve Repair Using a Percutaneous Mitral Valve Repair System. Schofer J, Tiburtius C, Hammerstingl C, Dickhaut PO, Witt J, Hansen L, Riess FC, Bijuklic K. J Am Coll Cardiol. 2016 Feb 23;67(7):889-90. doi: 10.1016/j.jacc.2015.11.047. PMID: 26892424 No abstract available.
Increased Risk of Cerebral Embolization After Implantation of a Balloon-Expandable Aortic Valve Without Prior Balloon Valvuloplasty. Bijuklic K, Haselbach T, Witt J, Krause K, Hansen L, Gehrckens R, Rieß FC, Schofer J. JACC Cardiovasc Interv. 2015 Oct;8(12):1608-13. doi: 10.1016/j.jcin.2015.07.013. Epub 2015 Sep 17. PMID: 26386760
Successful transfemoral Edwards SAPIEN 3 valve in valve implantation in a patient with a degenerated aortic bioprosthesis associated with severe paravalvular aortic regurgitation. Bijuklic K, Hansen L, Witt J, Schofer J. Clin Res Cardiol. 2015 Jan;104(1):92-3. doi: 10.1007/s00392-014-0760-9. Epub 2014 Sep 17. PMID: 25227426 No abstract available.